What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic review

INTRODUCTION: Clinical trials involving patients with Alzheimer's disease (AD) continue to try to identify disease-modifying treatments. Although trials are designed to meet regulatory and registration requirements, many do not measure outcomes of the disease most relevant to key stakeholders....

Descripción completa

Detalles Bibliográficos
Autores principales: Tochel, Claire, Smith, Michael, Baldwin, Helen, Gustavsson, Anders, Ly, Amanda, Bexelius, Christin, Nelson, Mia, Bintener, Christophe, Fantoni, Enrico, Garre-Olmo, Josep, Janssen, Olin, Jindra, Christoph, Jørgensen, Isabella F., McKeown, Alex, Öztürk, Buket, Ponjoan, Anna, Potashman, Michele H., Reed, Catherine, Roncancio-Diaz, Emilse, Vos, Stephanie, Sudlow, Cathie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Diagnostic Assessment & Prognosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411507/
https://www.ncbi.nlm.nih.gov/pubmed/30906845
http://dx.doi.org/10.1016/j.dadm.2018.12.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411507/
https://www.ncbi.nlm.nih.gov/pubmed/30906845
http://dx.doi.org/10.1016/j.dadm.2018.12.003

Ejemplares similares